Ultrastructural analysis of the distribution of von Willebrand factor and fibrinogen in platelet aggregates formed in the PFA-100®

Platelets

Volumn 9, Issue 6, 1998, Pages 381-389

  Poujol, C ^a   Nurden, A ^a   Paponneau, A ^a   Heilmann, E ^a   Nurden, P ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; CELL ADHESION MOLECULE; COLLAGEN; FIBRINOGEN; POLYCLONAL ANTIBODY; VON WILLEBRAND FACTOR;

ARTICLE; DEGRANULATION; DEVICE; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOGOLD STAINING; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE DYSFUNCTION; ULTRASTRUCTURE;

EID: 0031726893     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109876456     Document Type: Article

References (16)

1. Kundu SK, Sio R, Mitu A, Ostgaard RA. Evaluation of platelet function by PFA-100™. Clinical Chemistry 1994; 40: 1827-8.
2. Kundu SK, Heilman EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyser-PFA-100™. Sem Thromb Hemostas 1995; 21: 106-12.
3. Wilmer M, Sio R, Holde H-J, de Haan J. Characterization of preanalytical and technical variables when using the PFA-100TM test system. Ann Hematol (suppl. II) 1997; 74: A117 (abstract).
4. Kundu SK, Heilman EJ, Sio R, Garcia C, Ostgaard RA. Characterization of an in vitro platelet function analyser-PFA-100™. Clin Appl Thromb Hemostas 1996; 2: 241-9.
5. Hourdillé P, Heilmann E, Combrié R, Winckler J, Clemetson KJ, Nurden, AT. Thrombin induces a rapid redistribution of glycoprotein Ib-IX complexes within the membrane systems of activated human platelets. Blood 1990; 76: 1503-13.
6. Tokuyasu KT. A study of positive staining of ultratbin frozen sections. J Ultrastruct Res 1978, 63: 287-307.
7. Pidard D, Montgomery RR, Bennett JS, Kunicki TJ. Interaction of AP-2, a monoclonal antibody specific for human glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem 1983; 258: 12582-6.
8. Mannen EF, Alshameeri RS, Comp PC. Preliminary data from a field trial of the PFA-100™ system. Sem Thromb Hemostas 1995; 21: 113-21.
9. Fressinaud E, Veyradier A, Truchaud F, Martin I, Boyer-Neumann C, Meyer D. High sensitivity of the platelet function analyser (PFA-100™) for the screening of patients with von Willebrand disease: a study of twenty-six cases. Haemophilia 1996; 2: 96.
10. Muller M, Becker-Hagendorff K, Westrup D, Seifried E, Kirchmaier CM. PFA-100™ system: a sensitive screening test for platelet-related hemostasis defects. Ann Hematol (suppl. II) 1997; 74: A72 (abstract).
11. Humbert M, Nurden P, Bihour C, Pasquet J-M, Winckler J, Heilmann E, Savi P, Herbert J-M, Kunicki TJ, Nurden AT. Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation. Arterioscler Thromb Vasc Biol 1996, 16: 1532-43.
12. Heilmann E, Hourdillé P, Pruvost A, Paponneau A, Nurden AT. Thrombin-induced platelet aggregates have a dynamic structure. Time-dependent redistribution of glycoprotein IIb-IIIa complexes and secreted adhesive proteins. Arterioscler Thromb. 1991; 11: 704-18.
13. Weiss HJ, Hawiger J, Ruggeri ZM, Turitto VT, Thiagarajan P, Hoffman T. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest 1989; 83: 288-97.
14. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 1987; 69: 625-8.
15. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991; 87: 1234-40.
16. Heynen HFG, Lozano Molero M, de Groot PG, Nieuwenhuis HK, Sixma JJ. Absence of ligands bound to glycoprotein IIb-IIIa on the exposed surface of a thrombus may limit thrombus growth in flowing blood. J Clin Invest 1994; 94: 1098-112.